1.31 USD
▲+0.06+3.15%
盘后 1.29 +1.57%
2026-08-03
市值
$20.84M
市盈率
—
EPS
-0.72
股息率
—
52 周区间
0.77 – 2.35
成交量
117.39K
Beta
0.50
目标价
—
52W 低 0.7752W 高 2.35
价格走势
公司简介
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced ...